Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2026
Brii Biosciences discloses central lab test kit recall affecting ENHANCE trial HBsAg data
Brii Biosciences announced that on August 19, 2026, it received an email notice from a central laboratory service provider regarding a recall of a commercially available test kit batch (Roche Elecsys HBsAg II quant II) used for HBsAg testing in the ENHANCE study. The company stated the potential impact on its published clinical trial data appears limited to the end-of-treatment HBsAg data from ENHANCE Part A-2, and it is working with the provider to identify affected samples and arrange retesting with unaffected kits.
2022
Brii Biosciences released 2021 annual results
Brii Biosciences released its 2021 annual results and business update. The release reported a full-year loss of RMB 4.191 billion and outlined its pipeline and business progress.
2021
Brii Biosciences wins 2021 Research Achievement award
Brii Biosciences announced that it received the BioCentury-BayHelix “2021 R&D Achievement” Award, which recognized the company’s achievements in developing the BRII-196/BRII-198 combination therapy.